Skip to main content

Table 1 Characteristics of the patients included at the start of the follow-up period.

From: Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: A randomized controlled trial

Characteristics

NIPPV + rehabilitation

Rehabilitation

Subjects - n

24

32

Gender - M:F

16: 8

17: 15

Age - yrs, mean (SD)

63 (10)

61 (8)

Patients on LTOT - n (%)

14 (58%)

18 (56%)

BMI - kg/m2, mean (SD)

27.2 (5.1

27.0 (5.8

Active smokers, n (%)

5 (21%)

11 (34%)

Pack years - yrs, median (IQR)

42 (31-57)

43 (24-58)

Medication, n (%)

  

   inhaled corticosteroids

22 (92%)

29 (91%)

   oral corticosteroids

10 (42%)

14 (44%)

   bronch odilators

24 (100%)

31 (97%)

   theophylline

5 (21%)

8 (25%)

  1. Data are means (SD) or median (interquartile range, IQR), unless otherwise indicated. LTOT: long-term oxygen therapy; BMI: body mass index. Health-related quality of life scores, blood gases, exercise tolerance, and lung function data are presented in Figures 2-5 and additional file 1 tables 1-6.